CONTENTS
Contents 7. 8. 11.
Chapter 1: Clinical Operations & Outsourcing
AI for medical writers – friend or foe?
Global warning: Pharma’s role in the climate crisis With COP26 imminent, what lessons can the pharmaceutical sector learn about its environmental impact and its response to climate change?
15. 17.
“There will be a significant change in research and clinical trials in less than ten years”
Patient recruitment: Can pharmacists fill both prescriptions and clinical trials? As CVS, Walgreens and other retail pharmacy giants permeate the clinical trial space, questions remain about the effective integration into pharmacists’ workflows.
20. 23.
Key factors for a successful investigator meeting
Industry Viewpoint: Growing pains CTA sits down with clinical consultant Rita Nigam, who shines a spotlight on some of the obstacles that working with a small company presents.
26.
29. 30.
Eppendorf’s centrifuge solution for your clinical trial
Chapter 2: Technology & Data Management
It’s a match! Connecting patients to clinical trials with AI AI trial-matching platforms are overcoming the obstacles associated with clinical trial recruitment, but human oversight and data standardisation are crucial.
41. 36. 34.
Finding hidden treasure: How biotech and pharma can accelerate study timelines in Phase I and Phase II using trends hidden in the data they already have
Why is the healthcare industry hesitant to join the metaverse? The metaverse could improve access to care for all patients, regardless of their location.
38.
Breaking the mould: How digital endpoints could transform clinical trials The metaverse could improve access to care for all patients, regardless of their location.
Dynamic partnerships: Reshaping outsourcing models to empower small biotech marvels How service providers can offer tailored solutions to meet the specific needs of innovative, small biotech companies.
44. 45.
Chapter 3: Medical Devices
The applications and adoption of artificial intelligence (AI) in medical devices
49.
Collecting trial data outside the black box Wearable devices and remote sensors are key to unlocking decentralised clinical trials, but not all tech is created equal.
4 | Outsourcing In Clinical Trials
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72
